Redefining imaging genomics: AI-driven precision medicine enters the cross-modal era
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Dec-2025 23:11 ET (10-Dec-2025 04:11 GMT/UTC)
Recently, Hangzhou Institute of Medicine (HIM), University of Chinese Academy of Sciences (UCAS), Guangzhou National Laboratory and other research institutes published a perspective entitled Redefining imaging genomics for the next decade on Science Bulletin, in which the article systematically summarizes the existing advancements in imaging genomics, and proposes a framework for imaging genomics that provide a new path for precision medicine.
A new study shows that treating mesenchymal stem cells with lipopolysaccharide (LPS) shifts their energy use toward glycolysis, reducing their healing potential in stroke therapy — offering insights into improving cell-based treatments for brain injuries.
Co-senior authors Jeremy Levy of Pitt and Andrew Daley of Oxford, collaborators from the early days of the Pittsburgh Quantum Institute, wrote an explanatory analysis of their group’s chiral-electron findings publishing in Science Advances Friday. In this study that combines quantum physics, physics, biology, chemistry and organic systems, they developed in essence a programmable platform that could ultimately provide new ways to explore electrons in chiral systems — such as DNA, amino acids, proteins and more.